Research library
Mechanistic summaries of the published literature behind the compounds we supply — written for laboratory audiences, with sources named and evidence limits stated plainly.
The mechanistic link between NAD+ biosynthesis and insulin resistance, and why pooled human data on NAD+ precursor supplementation complicates the preclinical story.
Read the articleTwo mechanistically distinct peptide classes sit behind the term “GH secretagogue” — GHRH analogs such as tesamorelin, and ghrelin receptor agonists such as ipamorelin.
Read the articleHow BPC-157 and TB-500 differ mechanistically — nitric oxide and receptor signalling versus actin sequestration — and where their research literatures overlap and diverge.
Read the articleResearch Use Only
Intended solely for laboratory and in-vitro research by qualified professionals. Not approved for human consumption, veterinary use, or the diagnosis, treatment, cure, or prevention of any disease. Not a drug, supplement, food, or cosmetic.